• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Reddy's Laboratories Ltd.
    25 Jan 2025
    1321.70
    -0.08%
    Dr Reddys Laboratories Q3 Results 2025 on 25 Jan, 2025: profit rise by 2.38% YOY, profit at 1413.7 crore and revenue at 8381.2 crore
    Dr Reddys Laboratories Q3 Results 2025 on 25 Jan, 2025: profit rise by 2.38% YOY, profit at 1413.7 crore and revenue at 8381.2 crore
    livemint
    Dr Reddys Laboratories Q3 Results 2025 on 25 Jan, 2025: Revenue increased by 15.81% YoY & profit increased by 2.38% YoY, profit at 1413.7 crore and revenue at 8381.2 crore.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    logo
    Laurus Labs Ltd.
    25 Jan 2025
    10-year high
    932.10
    0.96%
    Laurus Labs Q3 Results 2025: Profit Soars 298.88% Year-on-Year
    Laurus Labs Q3 Results 2025: Profit Soars 298.88% Year-on-Year
    livemint
    Laurus Labs Q3 Results 2025 on 25 Jan, 2025: Revenue increased by 18.42% YoY & profit increased by 298.88% YoY, profit at 92.3 crore and revenue at 1415.05 crore.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
    logo
    Torrent Pharmaceuticals Ltd.
    24 Jan 2025
    3629.20
    1.73%
    Torrent Pharmaceuticals Q3 Results: Profit Up 13.5%; Meeting Estimates
    Torrent Pharmaceuticals Q3 Results: Profit Up 13.5%; Meeting Estimates
    NDTV Profit
    Torrent Pharmaceuticals Ltd.'s consolidated net profit rose 14% in the third quarter of the current financial year, in line with analysts' estimates.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    Torrent Pharma's profit rises 14% to 503 cr in Q3
    Business Line | 24 Jan 2025 4 more
    Torrent Pharma Q3 results: PAT up 14% at Rs 503 cr on strong India business
    Business Standard | 24 Jan 2025
    Torrent Pharma Q3 results: PAT rises 14% to Rs 503 cr, misses estimates
    Business Standard | 24 Jan 2025
    India's Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure
    livemint | 24 Jan 2025
    Torrent Pharma Q3 results: Net profit rises 14% YoY to 503 cr; Firm declares interim dividend of 26 …
    livemint | 24 Jan 2025
    logo
    Granules India Ltd.
    24 Jan 2025
    543.40
    0.05%
    Granules India's Q3 net down 6% at 117 crore
    Business Line
    Granules India's net profit declined 6 per cent at 117 crore in the third quarter ended December 2024 compared to 125 crore in the corresponding quarter of previous financial year.
    Copy LinkShare onShare on Share on Share on
    Granules India Ltd. has an average target of 615.75 from 4 brokers.
    Granules India Q3FY25 results: Net profit drops 6% to Rs 118 crore
    Business Standard | 24 Jan 2025 1 more
    Granules India Share Price Down After Q3 Revenue, Profit Fall
    NDTV Profit | 24 Jan 2025
    logo
    Laurus Labs Ltd.
    24 Jan 2025
    10-year high
    932.10
    0.96%
    Laurus Labs Q3 Results: Profit Grows Fourfold, Revenue Up 18%
    Laurus Labs Q3 Results: Profit Grows Fourfold, Revenue Up 18%
    NDTV Profit
    The pharmaceutical firm's margin expanded to 20.2% versus 15.2% in the year-ago period.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. is trading above all available SMAs
    logo
    Dr. Reddy's Laboratories Ltd.
    24 Jan 2025
    1321.70
    -0.08%
    Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
    Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
    livemint
    DR-REDDYS-STOCKS:Indian drugmaker Dr Reddy's shares slide after Q3 profit miss
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    Dr Reddy's shares plummet 4.4% in the wake of logging modest Q3 growth
    Business Line | 24 Jan 2025
    logo
    Syngene International Ltd.
    24 Jan 2025
    665.45
    1.14%
    Syngene Lowers FY25 Revenue Guidance, Yet Yes Securities Retains 'Buy' After Q3 Results - Here's Why
    Syngene Lowers FY25 Revenue Guidance, Yet Yes Securities Retains 'Buy' After Q3 Results - Here's Why
    NDTV Profit
    Syngene yet again cut its guidance, albeit marginally from high single to single digit growth as demand recovery linked to biotech funding was delayed by nearly a quarter.
    Copy LinkShare onShare on Share on Share on
    Syngene International Ltd. has lost -26.86% in the last 1 Year
    Syngene International Q3 Results 2025 on 24 Jan, 2025: profit rise by 17.58% YOY, profit at 131.1 crore …
    livemint | 24 Jan 2025 5 more
    Syngene International Share Price Down After FY25 Revenue Guidance Lowered
    NDTV Profit | 24 Jan 2025
    Syngene International Lowers FY25 Revenue Guidance Amid Market Challenges
    NDTV Profit | 24 Jan 2025
    Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6%
    Business Standard | 23 Jan 2025
    Syngene Q3 results: Net profit rises 17% to Rs 131 cr, revenue at Rs 944 cr
    Business Standard | 23 Jan 2025
    Syngene International Q3 Results: Profit Rises 17.6%, Misses Estimates
    NDTV Profit | 23 Jan 2025
    logo
    Mankind Pharma Ltd.
    24 Jan 2025
    2660.60
    0.85%
    Mankind Pharma shares crack 6% after Q3 profit drops 16%; know more
    Business Standard
    Mankind Pharma share slipped 5.61 per cent at Rs 2,487.15 a piece on the BSE in Friday's intraday trade
    Copy LinkShare onShare on Share on Share on
    Mankind Pharma Ltd. has an average target of 2840.50 from 2 brokers.
    Mankind Pharma Share Price Declines 5% After Q3 Profit Falls
    NDTV Profit | 24 Jan 2025 3 more
    Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25
    Economic Times | 23 Jan 2025
    Mankind Pharma Q3FY25 results: PAT falls 16.5%, revenue rises 24%
    Business Standard | 23 Jan 2025
    Mankind Pharma Q3 Results: Profit Falls 16%, Misses Estimates
    NDTV Profit | 23 Jan 2025
    logo
    Strides Pharma Science Ltd.
    24 Jan 2025
    871.00
    -0.54%
    Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
    Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
    NDTV Profit
    OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22
    Copy LinkShare onShare on Share on Share on
    Strides Pharma Scien.. has an average target of 1874.00 from 1 broker.
    logo
    Dr. Reddy's Laboratories Ltd.
    24 Jan 2025
    1321.70
    -0.08%
    Dr. Reddy's: Systematix Recommends 'Sell' On The Stock After Q3 Results Here's Why
    Dr. Reddy's: Systematix Recommends 'Sell' On The Stock After Q3 Results Here's Why
    NDTV Profit
    The brokerage expects Dr. Reddy's new business avenues to take a few years before they start contributing profitably to the consolidated performance.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1278.56 from 9 brokers.
    Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects
    Business Standard | 24 Jan 2025 9 more
    Dr Reddy's Laboratories share price declines 6% post Q3 results: Should you Buy, Sell or Hold ?
    livemint | 24 Jan 2025
    'Optimistic' about Trump administration, says drugmaker Dr Reddy's
    Business Standard | 23 Jan 2025
    Dr. Reddy's to focus on complex products as growth drivers to offset Revlimid revenue loss
    livemint | 23 Jan 2025
    Dr Reddy's Q3FY25 net up 2% at 1,413 cr
    Business Line | 23 Jan 2025
    Dr Reddy's Labs Q3 results: PAT rises 2.5% at Rs 1,413 cr, revenue up 16%
    Business Standard | 23 Jan 2025
    Dr Reddy's Labs Q3 Results: Profit grows 2% YoY to 1413 crore; revenue up 16%
    livemint | 23 Jan 2025
    Dr. Reddy's Laboratories Q3 Results: Profit Rises 2%, But Misses Estimates
    NDTV Profit | 23 Jan 2025
    Dr Reddy's Lab Q3 results: Profit up 2.5% at Rs 1,413 cr, revenue rises 16%
    Business Standard | 23 Jan 2025
    Dr. Reddy's Q3 FY25 net profit likely to remain flat
    Business Line | 23 Jan 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • JD Cables
    • GK Energy
    • Siddhi Cotspin
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd